Multivalent mRNA Vaccine Platform: Immunogenicity Data for Orthoebolaviruses

Jiachen Zhang developed a broad-spectrum mRNA vaccine candidate, [GPs+NP]@LNP, designed to protect against three major pathogenic orthoebolaviruses (EBOV, SUDV, BDBV). The dataset, last updated on 2026-04-30, contains experimental results likely detailing immune response measurements. The 101.3 KB XLSX file is shared under a CC-BY-4.0 license on figshare.

Use Cases

• Analyzing cross-reactive antibody responses based on the combination of glycoprotein (GP) antigens from three viruses.
• Modeling cellular immunity synergy based on the co-delivery of nucleoprotein (NP) with GPs.
• Evaluating vaccine platform efficacy based on the described broad-spectrum protection goal against orthoebolaviruses.
• Comparing immune response profiles based on the multivalent mRNA-LNP delivery system.

Strengths

• Data is shared under a permissive CC-BY-4.0 license, facilitating reuse.
• The 101.3 KB size indicates a focused, likely well-structured experimental dataset.
• The description provides a clear scientific hypothesis linking antigen combination to intended immune outcomes.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical analysis.
• The dataset's small scale (101.3 KB) suggests limited scope, potentially containing summary results rather than raw experimental data.

Provenance

Source

figshare, author Jiachen Zhang.

Collection Method

Likely contains experimental results from vaccine immunogenicity studies.

Time Range

null

Freshness

Last updated 2026-04 30 07:46:36; freshness should be verified.

Geography

null